Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

c-MET

c-MET, also called MET, is a membrane receptor that is essential for embryonic development and wound healing.

Items 1-10 of 24

Page
per page
  1. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: C-Met inhibitor,potent and ATP-competitive
  2. SU11274
    A2678 SU11274
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,potent and selective
      ≥28.4 mg/mL
  3. PF-04217903
    A5096 PF-04217903
    Target: c-MET
    Summary: C-Met inhibitor,selective and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥18.6 mg/mL
  4. SGX-523
    A1196 SGX-523
     1 Citation
    Target: MET
    Summary: MET inibitor, highly selective, ATP-competitive
      ≥17.95 mg/mL
  5. Cabozantinib (XL184, BMS-907351)
    A2977 Cabozantinib (XL184, BMS-907351)
    Summary: VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor
      ≥25.08 mg/mL
  6. JNJ-38877605
    A5092 JNJ-38877605
    Summary: C-Met inhibitor,ATP-competitive
      insoluble in H2O; ≥18.85 mg/mL
  7. AMG-208
    A1186 AMG-208
    Summary: C-Met inhibitor,potent and highly selective
      insoluble in EtOH; insoluble in H2O; ≥3.83 mg/mL
  8. BMS-777607
    A5703 BMS-777607
    Target: MET
    Summary: C-Met inhibitor, potent and selective
      ≥25.65 mg/mL
  9. Tivantinib (ARQ 197)
    A8325 Tivantinib (ARQ 197)
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,non-ATP-competitive
      ≥18.47 mg/mL
  10. AMG-458
    A8361 AMG-458
    Summary: Potent c-Met inhibitor
      Soluble in DMSO

Items 1-10 of 24

Page
per page